UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

The practice of consultation psychiatry in Italy: A multi-centre study

Journal of psychosomatic research, 2017-05, Vol.96, p.32-34

2017

Volltextzugriff (PDF)

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

The lancet oncology, 2011-11, Vol.12 (12), p.1101-1108

2011

Volltextzugriff (PDF)

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.766-776

2009

Volltextzugriff (PDF)

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

The lancet oncology, 2012-04, Vol.13 (4), p.420-432

2012

Volltextzugriff (PDF)

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection

Viruses, 2022-07, Vol.14 (7), p.1538

2022

Volltextzugriff (PDF)

DAR 16-II Primes Endothelial Cells for Angiogenesis Improving Bone Ingrowth in 3D-Printed BCP Scaffolds and Regeneration of Critically Sized Bone Defects

Biomolecules (Basel, Switzerland), 2022-11, Vol.12 (11), p.1619

2022

Volltextzugriff (PDF)

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Breast cancer research and treatment, 2012-01, Vol.131 (1), p.295-306

2012

Volltextzugriff (PDF)

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19586-19586

2007

Volltextzugriff (PDF)

Advanced breast cancer at presentation (ABC-p) in octogenarian women (OW): Specific elderly-devoted risk tests(SEDRT) (CARG+CRASH) as new tools to prevent serious/irreversible adverse reactions (AR) in frail patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12510-e12510

2021

Volltextzugriff (PDF)

Liquid biopsies in lung cancer: The new ambrosia of researchers

Biochimica et biophysica acta, 2014-12, Vol.1846 (2), p.539-546

2014

Volltextzugriff (PDF)

Prognostic impact of baseline circulating extracellular vesicles (BCEVs) in the setting of patients with advanced non-small cell lung cancer (ANSCLC) eligible for first line treatment with osimertinib

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14553-e14553

2023

Volltextzugriff (PDF)

Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems

Stem cells international, 2019-01, Vol.2019, p.7486279-16

2019

Volltextzugriff (PDF)

Cancer in the older person

Cancer treatment reviews, 2005-08, Vol.31 (5), p.380-402

2005

Volltextzugriff (PDF)

Modulating the release of bioactive molecules of human mesenchymal stromal cell secretome: Heparinization of hyaluronic acid-based hydrogels

International journal of pharmaceutics, 2024-03, Vol.653, p.123904-123904, Article 123904

2024

Volltextzugriff (PDF)

TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1

Scientific reports, 2020-07, Vol.10 (1), p.12067-12067, Article 12067

2020

Volltextzugriff (PDF)

Sex and Gender in Ageing and Longevity: Highlights From an International Course

Translational medicine @ UniSa, 2024, Vol.26 (1), p.15-29

2024

Volltextzugriff (PDF)

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Oncotarget, 2016-05, Vol.7 (19), p.28748-28760

2016

Volltextzugriff (PDF)

Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10592-10592

2023

Volltextzugriff (PDF)

Effects of erybuline/capecitabine (EC) treatment in very elderly women (VEW) with MBC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12508-e12508

2017

Volltextzugriff (PDF)

Treating cancer in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1699

2015

Volltextzugriff (PDF)

Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives

Cancers, 2024-06, Vol.16 (11), p.1967

2024

Volltextzugriff (PDF)

Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10519-10519

2022

Volltextzugriff (PDF)

Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21525-e21525

2022

Volltextzugriff (PDF)

Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2045

2021

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(109)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(42)
Humans
(41)
Aged
(20)
Oncology
(20)
Female
(17)
Biological And Medical Sciences
(16)
Male
(16)
Medical Sciences
(16)
Middle Aged
(14)
Proteins
(11)
Hematology, Oncology And Palliative Medicine
(10)
Tumors
(10)
Adult
(8)
Proteomics
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Chemotherapy
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The practice of consultation psychiatry in Italy: A multi-centre study

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection

DAR 16-II Primes Endothelial Cells for Angiogenesis Improving Bone Ingrowth in 3D-Printed BCP Scaffolds and Regeneration of Critically Sized Bone Defects

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Advanced breast cancer at presentation (ABC-p) in octogenarian women (OW): Specific elderly-devoted risk tests(SEDRT) (CARG+CRASH) as new tools to prevent serious/irreversible adverse reactions (AR) in frail patients

Liquid biopsies in lung cancer: The new ambrosia of researchers

Prognostic impact of baseline circulating extracellular vesicles (BCEVs) in the setting of patients with advanced non-small cell lung cancer (ANSCLC) eligible for first line treatment with osimertinib

Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems

Cancer in the older person

Modulating the release of bioactive molecules of human mesenchymal stromal cell secretome: Heparinization of hyaluronic acid-based hydrogels

TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1

Sex and Gender in Ageing and Longevity: Highlights From an International Course

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients

Effects of erybuline/capecitabine (EC) treatment in very elderly women (VEW) with MBC

Treating cancer in older and oldest old patients

Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives

Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)

Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab

Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis

Suchergebnisse filtern